InteRNA Technologies B.V.

One of the fastest moving fields in today's biomedical research concerns small non-coding RNAs in general and microRNA (miRNA) in particular. As insights into the role of these RNA species in health and disease are emerging at high speed, so are the opportunities for developing new diagnostic, prognostic and therapeutic applications.


InteRNA Technologies focuses on these developments by translating its proprietary miRNA sequences and discovery technologies into successful clinical and commercial products.

InteRNA Technologies has currently apporximately 15% of the human miRNA sequences in its patent portfolio.

News:

Press Releases:

22-4-2009: InteRNA Technologies and Radboud University Nijmegen
Medical Centre to Develop microRNA-based Therapeutics for
Prostate Cancer more information

7-11-2008: InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery more information

06-11-2008: InteRNA Technologies Joins European SIROCCO Consortium to Study RNA Silencing more information

30-10-2008: InteRNA Technologies and VU University Medical Center to Develop microRNA-based Diagnostics and Therapeutics for Cancer more information

Vacancies:

Technician R & D: more information

Bioinformatician: more information



InteRNA Technologies B.V.
Prof. Bronkhorstlaan 10-92
3723 MB Bilthoven
The Netherlands
T: +31 30 229 60 95
© 2007 InteRNA Technologies B.V. - Terms of Use - Contact